Advomedix Health

Advomedix Health One app for your whole family's health, from first feeding to final years.

08/18/2026

A quick heads-up on a trend blowing up online: "research-grade" peptides.

Here is the important distinction. Some peptides are real, FDA-approved medicine your doctor can prescribe. But there is a whole other group sold online "for research use only," and people are injecting them for weight loss, muscle, and anti-aging. Those have never been approved or tested for use in people.

Why medical boards are sounding the alarm: with no FDA oversight, there is no reliable way to know a vial's purity, potency, or sterility. That opens the door to contamination, wrong doses, infections, and bad reactions. And the safety data behind many of these is animal or lab only, not human.

This is not a fringe worry. A growing number of states, starting with a formal notice from the Alabama Board of Medical Examiners, have told clinicians not to prescribe, administer, or even recommend non-FDA-approved research-grade peptides, and a consent form does not remove that liability (Alabama Board of Medical Examiners, 2026).

One more thing to watch: a lot of the glowing before-and-afters are paid promotions. That discount code usually means the person earns a commission on your purchase.

Bottom line: talk to your doctor before you inject anything, and whatever you do take, keep it on one list. In advoMedix you can log every medication, supplement, and reaction in one place, so your doctor and the ER always know exactly what is in your system.

Free on iOS and Android. Search advoMedix in the App Store.

A real breakthrough for one of the hardest cancers to treat. 🧬In a phase 3 trial for advanced pancreatic cancer, an expe...
08/17/2026

A real breakthrough for one of the hardest cancers to treat. 🧬

In a phase 3 trial for advanced pancreatic cancer, an experimental once-daily pill called daraxonrasib nearly doubled median survival: 13.2 months versus 6.7 on chemotherapy (Memorial Sloan Kettering). It is not a cure, but for this disease it is a meaningful step.

How it works: it targets KRAS mutations that drive more than 90% of pancreatic cancers and were long thought undruggable, acting like a molecular switch that turns the cancer-driving protein off. Being targeted, its side effects were mostly manageable, like rash or mouth sores (MSKCC, Stanford Medicine).

The reality: it is still experimental, available now only through the FDA's expanded access program for certain post-chemo patients, and it holds Breakthrough Therapy and Orphan Drug status. Larger first-line trials are underway (UCHealth, FDA).

Facing a diagnosis, or supporting someone who is? Keep your records, treatments, and questions in advoMedix for your oncologist, and ask about clinical trials. Free on iOS and Android. Search advoMedix.

Sending strength to every family in this fight.

08/09/2026

Some genuinely hopeful news out of cancer research this month.

An experimental once-daily pill for advanced pancreatic cancer, one of the deadliest cancers, roughly doubled how long patients lived in a large phase 3 trial. Median survival was 13.2 months, compared with 6.7 months on standard chemotherapy (RASolute 302 trial, New England Journal of Medicine, 2026).

What makes it different: instead of hitting the whole body like chemo, it targets KRAS, a mutation that drives more than 90% of pancreatic cancers and was long considered impossible to drug. Because it is targeted, side effects were generally more manageable, often skin rash or mouth sores rather than the full toll of chemo.

An honest note, because this matters: it is still experimental, it is not a cure, and in this trial it was a second-line option for people already treated. It is currently reachable only through the FDA's expanded access program, which a treating physician has to request. If this is relevant to you or someone you love, talk to your oncologist about whether it fits.

The bigger shift here is precision medicine: the right treatment increasingly depends on your specific diagnosis, biomarker and test results, and family history. Keeping all of that organized helps you and your care team weigh targeted options and trials. That is what advoMedix is for: your diagnoses, test results, medications, and family history in one place, ready to share with the people treating you.

Free on iOS and Android. Search advoMedix in the App Store.

Brain fog often starts on your plate. 🫐What you eat swings your blood sugar and inflammation, which shows up as focus, m...
08/08/2026

Brain fog often starts on your plate. 🫐

What you eat swings your blood sugar and inflammation, which shows up as focus, memory, and mood. Whole foods steady it, ultra-processed foods fog it up (Harvard Health).

Eat these: fatty fish (omega-3s), berries (antioxidants), walnuts and seeds, leafy greens, eggs (choline), and whole grains for steady energy (Mass General Brigham).

Limit these: added sugars and soda, refined carbs, ultra-processed and fast food, alcohol, and gluten or dairy if you are sensitive.

A simple test: cut the usual suspects for a couple of weeks and see if the fog lifts.

Notice a pattern? Log how you feel over a few weeks in advoMedix and share it with your doctor. Free on iOS and Android. Search advoMedix.

Which food gives you the afternoon crash?

"GLP-1s cut breast cancer risk 30%." Great headline. Here's the math. 🧮A Penn Medicine study of 100,000+ women found 1.6...
08/06/2026

"GLP-1s cut breast cancer risk 30%." Great headline. Here's the math. 🧮

A Penn Medicine study of 100,000+ women found 1.6% of GLP-1 users were diagnosed with breast cancer versus 2.3% of non-users. That is the "30% lower" figure, but in absolute terms it is a difference of less than one percentage point (Penn Medicine).

Why the caution: it is observational, so it shows a link, not prevention. The women were not randomly assigned, and it did not track exercise, alcohol, family history, or genetics, any of which could explain the small gap.

There is a plausible thread (obesity is a pro-inflammatory state, and GLP-1s reduce weight and inflammation), but plausible is not proven. This needs randomized clinical trials.

The takeaway: this is not a reason to take a GLP-1 for cancer prevention. Know your risk factors and keep up with screening, track it in advoMedix, and talk to your doctor. Free on iOS and Android. Search advoMedix.

How do you tell hype from science?

Before you let an influencer talk you into injecting peptides, read this. ⚠️Some peptides are legitimate FDA-approved dr...
08/05/2026

Before you let an influencer talk you into injecting peptides, read this. ⚠️

Some peptides are legitimate FDA-approved drugs (insulin and semaglutide are peptides). But a gray market of vials is being sold online "for research use only" and injected for weight loss, muscle, and anti-aging. Multiple state medical boards, starting with Alabama, are telling doctors to stop prescribing them (Alabama Board of Medical Examiners).

Why the alarm: "research use only" means purity, potency, and sterility are not guaranteed; contaminants and wrong doses can cause infections and reactions; and popular ones like BPC-157 and TB-500 have only animal or lab data, not proven human safety.

Gray-market vials are not approved or tested in people, and a waiver does not make them safe. Talk to a licensed clinician first.

Keep a list of everything you take, including anything you inject, in advoMedix, and share it with your doctor. Free on iOS and Android. Search advoMedix.

Have you seen these ads?

No gym, no weights, no excuses. Your body is the gym. 💪Bodyweight moves like squats, lunges, and planks build strength, ...
08/04/2026

No gym, no weights, no excuses. Your body is the gym. 💪

Bodyweight moves like squats, lunges, and planks build strength, protect your joints, and get your heart rate up anywhere. Strength work also supports your heart, mood, sleep, and blood sugar (Harvard Health, Mayo Clinic).

Five wins, zero equipment: lean muscle, better heart fitness, more mobility, fat loss, and less joint stress than heavy lifting.

No weights? Make it harder: slow every rep for time under tension, hold at the hardest point, train one leg at a time, and keep adding a little each time.

Then make it stick: build your routine, schedule your training days, and log every set in advoMedix, and watch your progress over time.

Free on iOS and Android. Search advoMedix.

What is your go-to no-equipment move?

08/03/2026

The American Cancer Society just updated its colorectal cancer screening guidelines, and the headline is simple: if you are 45 and at average risk, it is time to start.

Why the change: colon cancer is rising fast in younger adults, so regular screening now begins at 45 and continues through about 75 (American Cancer Society, 2026).

You have options, ranked best to backup:
1. Colonoscopy, the gold standard, every 10 years. It can find and remove polyps in one visit.
2. An at-home stool test, every 3 years for the newer options.
3. A blood test, added for people who would otherwise skip screening entirely. It is the least sensitive, not the preferred choice, and coverage can vary.

One key catch: if an at-home stool or blood test comes back positive, you still need a follow-up colonoscopy, ideally within 6 months. The real rule of thumb: the best test is the one you actually get done.

Do not let it slip. In advoMedix you can log your screening and its result, note when the next one is due, and record your family history, which can be a reason to start before 45. Then walk into your appointment with the full picture.

Talk to your doctor about which option is right for you.

Free on iOS and Android. Search advoMedix in the App Store.

Not today, cancer. 🚫The American Cancer Society updated its colorectal cancer screening guidelines. Screening now starts...
08/02/2026

Not today, cancer. 🚫

The American Cancer Society updated its colorectal cancer screening guidelines. Screening now starts at 45 for average-risk adults and runs through 75 for those in good health. From 76 to 85 it is a decision with your doctor, and over 85 it is generally no longer advised (ACS).

Why the change? Colorectal cancer is rising in people under 50, and about 1 in 3 who should be screened are not.

The rule is simple: the best test is the one you actually do.

1. Colonoscopy every 10 years, the gold standard, it finds and removes polyps.
2. At-home stool test every 1 to 3 years, depending on the test.
3. Blood test, only if you would otherwise skip screening, it is the least sensitive.

Any abnormal at-home result needs a follow-up colonoscopy (ACS).

Turning 45 or overdue? Ask your doctor which test fits, and track your screening dates and results in advoMedix so you know when you are due. Free on iOS and Android. Search advoMedix.

Tag someone who needs the nudge.

08/01/2026

That mid-afternoon fog is not just about sleep. A lot of it comes down to what and when you ate.

The pattern is simple. Foods that spike your blood sugar and drive inflammation tend to leave your brain sluggish. Foods that keep both steady help you think clearly.

Feed your focus with fatty fish, walnuts, and eggs, plenty of berries and leafy greens, and olive oil and whole grains. In one large Harvard study, people who had over half a spoon of olive oil a day had about 28% lower risk of dementia-related death, regardless of overall diet quality (Tessier et al., JAMA Network Open, 2024).

What tends to fog you up: sugary drinks and refined carbs, ultra-processed foods, and too much alcohol. You do not have to be perfect. Small, steady swaps do the work.

Want to see the connection for yourself? If you track your blood sugar, advoMedix shows how your meals move it, flags the post-meal spikes, and keeps the pattern organized to share with your doctor. If your fog is persistent, that record makes the conversation easier.

Free on iOS and Android. Search advoMedix in the App Store.

Address

New York, NY

Alerts

Be the first to know and let us send you an email when Advomedix Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share